The Global Molecular Diagnostics Market, June 2015

The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019.  This growth is forecast to occur in spite of relatively modest growth in the overall worldwide market for IVD products, which is estimated to be expanding at a compound annual rate of 4.2% for the same period.  To some extent, growth of the molecular diagnostics market will occur at the expense of certain segments of the conventional diagnostic products market, including cell culture testing, immunoassay products for infectious diseases, immunoassays for cancer diagnosis and screening, and conventional products for genetic testing.  Individual product segments covered in this report include molecular diagnostics for infectious disease, blood screening, genetic testing, and cancer diagnosis and screening.

This report covers:

• worldwide procedure and market forecasts for the years 2014 to 2019;
• key factors influencing the growth of individual product markets;
• estimated market shares and sales among leading suppliers;
• major supplier product portfolio analysis in individual product markets;
• emerging companies developing novel molecular diagnostic assays;
• emerging areas of opportunity in the molecular diagnostic market; and,
• innovative technology that could potentially change the way product markets develop.